Trends in anti-D immune globulin for childhood immune thrombocytopenia: usage, response rates, and adverse effects.
about
Anti-D immunoglobulin therapy for pediatric ITP: before and after the FDA's black box warning.Acute hemolysis after intravenous immunoglobulin amid host factors of ABO-mismatched bone marrow transplantation, inflammation, and activated mononuclear phagocytes.High dose Intravenous Anti-D Immune Globulin is More Effective and Safe in Indian Paediatric Patients of Immune Thrombocytopenic Purpura.Intramuscular anti-D in chronic immune thrombocytopenia children with severe thrombocytopenia.
P2860
Trends in anti-D immune globulin for childhood immune thrombocytopenia: usage, response rates, and adverse effects.
description
2011 nî lūn-bûn
@nan
2011 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Trends in anti-D immune globul ...... se rates, and adverse effects.
@ast
Trends in anti-D immune globul ...... se rates, and adverse effects.
@en
type
label
Trends in anti-D immune globul ...... se rates, and adverse effects.
@ast
Trends in anti-D immune globul ...... se rates, and adverse effects.
@en
prefLabel
Trends in anti-D immune globul ...... se rates, and adverse effects.
@ast
Trends in anti-D immune globul ...... se rates, and adverse effects.
@en
P2093
P2860
P356
P1476
Trends in anti-D immune globul ...... se rates, and adverse effects.
@en
P2093
Leslie A Kalish
Michelle Long
Rachael F Grace
P2860
P304
P356
10.1002/AJH.22261
P577
2011-12-21T00:00:00Z